Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention.

Sharma M, Dong Q, Hirano T, Kasner SE, Saver J, Masjuan J, Demchuk AM, Cordonnier C, Bereczki D, Tsivgoulis G, Veltkamp R, Staikov I, Bae HJ, Campbell BCV, Zini A, Lee IH, Ameriso S, Kovar M, Mikulik R, Lemmens R, Ferro JM, Robinson T, Christensen H, Ozturk S, Leker RR, Turcani P, Slowik A, Amaya P, Hoo FK, De Marchis GM, Knoflach M, Sylaja PN, Putaala J, Coutinho JM, Worp HBV, Miglane E, Matijosaitis V, Lindgren AG, Silva GS, Sandset EC, Turuspekova ST, Joundi RA, Schulze K, Shestakovska O, Gilbride J, Bangdiwala SI, Xu L, Muehlhofer E, Colorado P, Mundl H, Keller L, Shoamanesh A.

Open source

DOI
10.1093/esj/aakaf017
Published
2026-01-01
Container
Eur Stroke J
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/esj/aakaf017,
  title = {Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention.},
  author = {Sharma M and  Dong Q and  Hirano T and  Kasner SE and  Saver J and  Masjuan J and  Demchuk AM and  Cordonnier C and  Bereczki D and  Tsivgoulis G and  Veltkamp R and  Staikov I and  Bae HJ and  Campbell BCV and  Zini A and  Lee IH and  Ameriso S and  Kovar M and  Mikulik R and  Lemmens R and  Ferro JM and  Robinson T and  Christensen H and  Ozturk S and  Leker RR and  Turcani P and  Slowik A and  Amaya P and  Hoo FK and  De Marchis GM and  Knoflach M and  Sylaja PN and  Putaala J and  Coutinho JM and  Worp HBV and  Miglane E and  Matijosaitis V and  Lindgren AG and  Silva GS and  Sandset EC and  Turuspekova ST and  Joundi RA and  Schulze K and  Shestakovska O and  Gilbride J and  Bangdiwala SI and  Xu L and  Muehlhofer E and  Colorado P and  Mundl H and  Keller L and  Shoamanesh A.},
  year = {2026},
  journal = {Eur Stroke J},
  doi = {10.1093/esj/aakaf017},
  url = {https://doi.org/10.1093/esj/aakaf017}
}

RIS

TY  - JOUR
TI  - Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention.
AU  - Sharma M
AU  -  Dong Q
AU  -  Hirano T
AU  -  Kasner SE
AU  -  Saver J
AU  -  Masjuan J
AU  -  Demchuk AM
AU  -  Cordonnier C
AU  -  Bereczki D
AU  -  Tsivgoulis G
AU  -  Veltkamp R
AU  -  Staikov I
AU  -  Bae HJ
AU  -  Campbell BCV
AU  -  Zini A
AU  -  Lee IH
AU  -  Ameriso S
AU  -  Kovar M
AU  -  Mikulik R
AU  -  Lemmens R
AU  -  Ferro JM
AU  -  Robinson T
AU  -  Christensen H
AU  -  Ozturk S
AU  -  Leker RR
AU  -  Turcani P
AU  -  Slowik A
AU  -  Amaya P
AU  -  Hoo FK
AU  -  De Marchis GM
AU  -  Knoflach M
AU  -  Sylaja PN
AU  -  Putaala J
AU  -  Coutinho JM
AU  -  Worp HBV
AU  -  Miglane E
AU  -  Matijosaitis V
AU  -  Lindgren AG
AU  -  Silva GS
AU  -  Sandset EC
AU  -  Turuspekova ST
AU  -  Joundi RA
AU  -  Schulze K
AU  -  Shestakovska O
AU  -  Gilbride J
AU  -  Bangdiwala SI
AU  -  Xu L
AU  -  Muehlhofer E
AU  -  Colorado P
AU  -  Mundl H
AU  -  Keller L
AU  -  Shoamanesh A.
PY  - 2026
JO  - Eur Stroke J
DO  - 10.1093/esj/aakaf017
UR  - https://doi.org/10.1093/esj/aakaf017
ER  -

APA

M, S., Q, D., T, H., SE, K., J, S., J, M., AM, D., C, C., D, B., G, T., R, V., I, S., HJ, B., BCV, C., A, Z., IH, L., S, A., M, K., R, M., R, L., JM, F., T, R., H, C., S, O., RR, L., P, T., A, S., P, A., FK, H., GM, D. M., M, K., PN, S., J, P., JM, C., HBV, W., E, M., V, M., AG, L., GS, S., EC, S., ST, T., RA, J., K, S., O, S., J, G., SI, B., L, X., E, M., P, C., H, M., L, K., & A., S. (2026). Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention.. Eur Stroke J. https://doi.org/10.1093/esj/aakaf017

Source records